Showing results (81-90 of 227) with videos related to

Sort By:
Pageof 23
Blood Research|October 13, 2018
Bendamustine, etoposide, and dexamethasone to mobilize peripheral blood hematopoietic stem cells for autologous transplantation in non-Hodgkin lymphomaAdam M Greenbaum, Damian J Green, Leona A Holmberg, et al.
Blood|January 21, 2010
Platelet-derived thrombospondin-1 is a critical negative regulator and potential biomarker of angiogenesisAlexander Zaslavsky, Kwan-Hyuck Baek, Ryan C Lynch, et al.
Nature Communications|October 27, 2010
Biogeography and habitat modelling of high-alpine bacteriaAndrew J King, Kristen R Freeman, Katherine F McCormick, et al.
Clinical Trials (London, England)|May 8, 2016
Response assessment in lymphoma: Concordance between independent central review and local evaluation in a clinical trial settingAjay K Gopal, Barbara Pro, Joseph M Connors, et al.
Investigational New Drugs|June 15, 2014
Phase 1b study of otlertuzumab (TRU-016), an anti-CD37 monospecific ADAPTIR™ therapeutic protein, in combination with rituximab and bendamustine in relapsed indolent lymphoma patientsAjay K Gopal, Stefano R Tarantolo, Naresh Bellam, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 21, 2006
Improving the efficacy of reduced intensity allogeneic transplantation for lymphoma using radioimmunotherapyAjay K Gopal, John M Pagel, Joseph G Rajendran, et al.
International Journal of Hematologic Oncology|November 29, 2021
A Phase I trial of talazoparib in patients with advanced hematologic malignanciesAjay K Gopal, Rakesh Popat, Ryan J Mattison, et al.
Cancer|July 16, 2008
High-dose therapy and autologous stem cell transplantation for chemoresistant Hodgkin lymphoma: the Seattle experienceAjay K Gopal, Tracee L Metcalfe, Ted A Gooley, et al.
British Journal of Clinical Pharmacology|April 27, 2016
Brentuximab vedotin, an antibody-drug conjugate, in patients with CD30-positive haematologic malignancies and hepatic or renal impairmentBaiteng Zhao, Robert Chen, Owen A O'Connor, et al.
Leukemia & Lymphoma|May 3, 2008
Effect of remission status and induction chemotherapy regimen on outcome of autologous stem cell transplantation for mantle cell lymphomaBrian G Till, Theodore A Gooley, Nathan Crawford, et al.
Pageof 23